Patients Who Have Completed a Previous Oncology Study With Olaparib (ROSY-O)
Enrolling By Invitation
18 years - 99 years
Female
Phase
N/A
3 participants needed
1 Location
Brief description of study
Prior participants of ROSY-O study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Ovarian Cancer,Breast Cancer,Cancer
-
Age: 18 years - 99 years
-
Gender: Female
Females Age 18-99 prior participation in ROSY-O study
Updated on
04 Aug 2024.
Study ID: 844167
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
